Literature DB >> 21235515

Design, synthesis and preliminary evaluation of novel imperatorin derivatives as vasorelaxant agents.

Na Li1, Jianyu He, Yingzhuan Zhan, Nan Zhou, Jie Zhang.   

Abstract

A series of novel imperatorin derivatives were synthesized from commercially available xanthotoxin. The in vitro pharmacological evaluation indicated that all of the compounds possessed potent vasodilatory activity. Among them, compounds (5b), (5d) and (5e) exhibited higher vasdilatory activity (with EC(50) values of 0.68 µM, 0.59 µM and 0.49 µM, respectively) than imperatorin (EC(50) = 1.12 µM). The program Volsurf was used to predict the derivatives' ADME-relevant descriptors. The results suggested that these novel compounds had a potential interest for the development of novel and potent vasorelaxant agents.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21235515     DOI: 10.2174/157340611794072715

Source DB:  PubMed          Journal:  Med Chem        ISSN: 1573-4064            Impact factor:   2.745


  1 in total

1.  Imperatorin inhibits mitogen-activated protein kinase and nuclear factor kappa-B signaling pathways and alleviates neuroinflammation in ischemic stroke.

Authors:  Jian-Wei Ge; Shi-Ji Deng; Zhi-Wei Xue; Pin-Yi Liu; Lin-Jie Yu; Jiang-Nan Li; Sheng-Nan Xia; Yue Gu; Xin-Yu Bao; Zhen Lan; Yun Xu; Xiao-Lei Zhu
Journal:  CNS Neurosci Ther       Date:  2021-10-21       Impact factor: 5.243

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.